» Articles » PMID: 17478522

Complexities Associated with Expression of Epstein-Barr Virus (EBV) Lytic Origins of DNA Replication

Overview
Specialty Biochemistry
Date 2007 May 5
PMID 17478522
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

EBV has two lytic origins (oriLyt) of DNA replication lying at divergent sites on the viral genome within a duplicated sequence (DS). The latter contains potential hairpin loops, 'hinge' elements and the promoters for transcripts from viral genes BHLF1 and LF3. These genes themselves consist largely of 125 and 102 bp repetitive sequences, respectively, and encode basic proteins. We have examined these genomic regions in detail in attempts to understand why lytic replication--necessary for virus survival--is so inefficient, and to identify controlling elements. Our studies uncovered a diverse family of promoters (P) for BHLF1 and LF3, only one pair of which (P1) proved sensitive to chemical inducing agents. The others (P2-P3/4), abutting the replication 'core' origin elements in DS and extending into 5'-unique sequences, may play roles in the maintenance of viral latency. We further identified a family of overlapping small complementary-strand RNAs that transverse the replication 'core' origin elements in a manner suggesting a role for them as 'antisense' species and/or DNA replication primers. Our data are discussed in terms of alternative lytic replication models. We suggest our findings might prove useful in seeking better control over viral lytic replication and devising strategies for therapy.

Citing Articles

Long non-coding RNAs in Epstein-Barr virus-related cancer.

Liu Y, Hu Z, Zhang Y, Wang C Cancer Cell Int. 2021; 21(1):278.

PMID: 34034760 PMC: 8144696. DOI: 10.1186/s12935-021-01986-w.


Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma.

Yu F, Syn N, Lu Y, Chong Q, Lai J, Tan W Front Oncol. 2021; 11:626659.

PMID: 33898307 PMC: 8059411. DOI: 10.3389/fonc.2021.626659.


The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.

Yetming K, Lupey-Green L, Biryukov S, Hughes D, Marendy E, Miranda J J Virol. 2020; 94(17).

PMID: 32581094 PMC: 7431786. DOI: 10.1128/JVI.01215-20.


A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Majerciak V, Yang W, Zheng J, Zhu J, Zheng Z J Virol. 2018; 93(2).

PMID: 30355690 PMC: 6321932. DOI: 10.1128/JVI.01593-18.


The Epstein Barr virus circRNAome.

Ungerleider N, Concha M, Lin Z, Roberts C, Wang X, Cao S PLoS Pathog. 2018; 14(8):e1007206.

PMID: 30080890 PMC: 6095625. DOI: 10.1371/journal.ppat.1007206.


References
1.
Feng W, Hong G, Delecluse H, Kenney S . Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J Virol. 2004; 78(4):1893-902. PMC: 369434. DOI: 10.1128/jvi.78.4.1893-1902.2004. View

2.
Dolan A, Addison C, Gatherer D, Davison A, McGeoch D . The genome of Epstein-Barr virus type 2 strain AG876. Virology. 2006; 350(1):164-70. DOI: 10.1016/j.virol.2006.01.015. View

3.
Pfeffer S, Zavolan M, Grasser F, Chien M, Russo J, Ju J . Identification of virus-encoded microRNAs. Science. 2004; 304(5671):734-6. DOI: 10.1126/science.1096781. View

4.
Jones M, Foster L, Sheedy T, Griffin B . The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J. 1984; 3(4):813-21. PMC: 557432. DOI: 10.1002/j.1460-2075.1984.tb01890.x. View

5.
Baer R, Bankier A, Biggin M, Deininger P, Farrell P, Gibson T . DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984; 310(5974):207-11. DOI: 10.1038/310207a0. View